Deleted Tweets From Scott Gottlieb, R-D.C.

#FDA approved a record number of 126 generic drugs in July: 96 full approvals + 30 tentative approvals. Another sign that investments in the generic drug program and our commitment to timely approval of safe, effective, high quality generics are paying off https://t.co/vaSzgrHkyJ

RT @SGottliebFDA: @DanMunro @XSSniper @US_FDA #FDA is appreciative of our work and collaboration with the white hat hacker community,… https://t.co/TNCJ8Jpsdu

@DanMunro @XSSniper @US_FDA #FDA is appreciative of our work and collaboration with the white hat hacker community, and their help in identifying vulnerabilities. Improving MedTech cybersecurity requires this open dialogue. We’re advancing new efforts to achieve cybersecurity goals. #BlackHat2018 @XSAniper

RT @tmprowell: There’s an easy way for anyone to report to #FDA “bad ads,” prescription drug advertising that is misleading or unt… https://t.co/5t4qQZldYw

RT @RAPSorg: July Marks All-Time High in @US_FDA Generic Drug Approvals | #Regulatory Focus https://t.co/KiceQB2pvz #FDA #genericdrugs #pharma

RT @FDAOncology: #FDAOncology article via @JNCI_Now provides an update on oncology/hematology drug approvals from 2008 to 2016, with… https://t.co/cuKe2U1XWu

RT @US_FDA: FDA Commissioner @SGottliebFDA speaking at the @NHCouncil #puttingpatientsfirst this morning. https://t.co/a6JNBEENX9

#FDA values the important work of security researchers like those presenting at #BlackHat. Security researchers who engage with industry, FDA and the medical community can provide important insight into med device vulnerabilities. https://t.co/hZRCOtDjvi

Hey @stephenathome, can’t you do better than a T-shirt? https://t.co/qfreAwkuFa

#FDA issued new guidance on our intent not to enforce labeling and warning statement requirements for cigars and pipe tobacco at this time. https://t.co/HjgnKXaOZk  We’ve also revised five guidances to reflect this compliance policy for these products. https://t.co/pR754iUWow QT @FDATobacco: Reminder: By Aug. 10, all packages and advertisements for “covered” tobacco products (except for cigars and pipe to… https://t.co/zHyyfAMcF5)

Presentations about potential cyber vulnerabilities of medical devices can help industry, #FDA and the medical community identify and address cyber risks. Thank you to the presenters at #BlackHat for working with #FDA to address medical device cybersecurity

RT @NHCouncil: @SGottliebFDA and NHC’s Marc Boutin discuss meaningful #patientengagement and how the @US_FDA is… https://t.co/NyyuuqbP6Q

RT @FDATobacco: The order letters and summary reviews, which include the scientific basis for today’s action, are available on our… https://t.co/gzSKFMyxQ3

RT @FDAOncology: Today #FDAOncology @US_FDA released a draft guidance for industry, Expansion Cohorts: Use in First-In-Human Clinica… https://t.co/sRoxcdd36D

RT @SecAzar: Great meeting with @SGottliebFDA today about the important work being done by @US_FDA. We discussed the record numb… https://t.co/YKPVAr4HiW

RT @SecAzar: Last year, @US_FDA approved a record number of generic drugs in a year, more than 1,000. This July, they approved a… https://t.co/rBFus3LOW9

RT @SecAzar: This is a key way to drive down drug prices through market competition, and one the U.S. does better than much of t… https://t.co/lkqunF2Ouv

RT @SecAzar: Why are these approvals so important for American patients? Because generic drug competition drives prices down—a l… https://t.co/EjqqAh2G7T

RT @FDAMedia: FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease https://t.co/y1UI4Mq3pc

RT @FDAOncology: New to cancer patient advocacy and wondering how to get involved with FDA? Register now for #FDAOncology's 2nd annu… https://t.co/NKddUKzknM

#FDA approved a record number of 126 generic drugs in July: 96 full approvals + 30 tentative approvals. Another sign that investments in the generic drug program and our commitment to timely approval of safe, effective, high quality generics are paying off https://t.co/vaSzgrHkyJ

RT @SGottliebFDA: @DanMunro @XSSniper @US_FDA #FDA is appreciative of our work and collaboration with the white hat hacker community,… https://t.co/TNCJ8Jpsdu

@DanMunro @XSSniper @US_FDA #FDA is appreciative of our work and collaboration with the white hat hacker community, and their help in identifying vulnerabilities. Improving MedTech cybersecurity requires this open dialogue. We’re advancing new efforts to achieve cybersecurity goals. #BlackHat2018 @XSAniper

RT @tmprowell: There’s an easy way for anyone to report to #FDA “bad ads,” prescription drug advertising that is misleading or unt… https://t.co/5t4qQZldYw

RT @RAPSorg: July Marks All-Time High in @US_FDA Generic Drug Approvals | #Regulatory Focus https://t.co/KiceQB2pvz #FDA #genericdrugs #pharma

RT @FDAOncology: #FDAOncology article via @JNCI_Now provides an update on oncology/hematology drug approvals from 2008 to 2016, with… https://t.co/cuKe2U1XWu

RT @US_FDA: FDA Commissioner @SGottliebFDA speaking at the @NHCouncil #puttingpatientsfirst this morning. https://t.co/a6JNBEENX9

#FDA values the important work of security researchers like those presenting at #BlackHat. Security researchers who engage with industry, FDA and the medical community can provide important insight into med device vulnerabilities. https://t.co/hZRCOtDjvi

Hey @stephenathome, can’t you do better than a T-shirt? https://t.co/qfreAwkuFa

#FDA issued new guidance on our intent not to enforce labeling and warning statement requirements for cigars and pipe tobacco at this time. https://t.co/HjgnKXaOZk  We’ve also revised five guidances to reflect this compliance policy for these products. https://t.co/pR754iUWow QT @FDATobacco: Reminder: By Aug. 10, all packages and advertisements for “covered” tobacco products (except for cigars and pipe to… https://t.co/zHyyfAMcF5)

Presentations about potential cyber vulnerabilities of medical devices can help industry, #FDA and the medical community identify and address cyber risks. Thank you to the presenters at #BlackHat for working with #FDA to address medical device cybersecurity

RT @NHCouncil: @SGottliebFDA and NHC’s Marc Boutin discuss meaningful #patientengagement and how the @US_FDA is… https://t.co/NyyuuqbP6Q

RT @FDATobacco: The order letters and summary reviews, which include the scientific basis for today’s action, are available on our… https://t.co/gzSKFMyxQ3

RT @FDAOncology: Today #FDAOncology @US_FDA released a draft guidance for industry, Expansion Cohorts: Use in First-In-Human Clinica… https://t.co/sRoxcdd36D

RT @SecAzar: Great meeting with @SGottliebFDA today about the important work being done by @US_FDA. We discussed the record numb… https://t.co/YKPVAr4HiW

RT @SecAzar: Last year, @US_FDA approved a record number of generic drugs in a year, more than 1,000. This July, they approved a… https://t.co/rBFus3LOW9

RT @SecAzar: This is a key way to drive down drug prices through market competition, and one the U.S. does better than much of t… https://t.co/lkqunF2Ouv

RT @SecAzar: Why are these approvals so important for American patients? Because generic drug competition drives prices down—a l… https://t.co/EjqqAh2G7T

RT @FDAMedia: FDA approves first-of-its kind targeted RNA-based therapy to treat a rare disease https://t.co/y1UI4Mq3pc

RT @FDAOncology: New to cancer patient advocacy and wondering how to get involved with FDA? Register now for #FDAOncology's 2nd annu… https://t.co/NKddUKzknM